Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS30000836
Basic Information
VIS ID
TVIS30000836
Fusion event
HIV-FOXN2 integration
Validated
No
Detection method
QiaQuick PCR and Sequencing
Data source
download(RID)
Sample type
Cell line
Disease
HIV-infected disease (HID)
Quality evaluation
Normal
Reported year
2016
PubMed ID
26912621
Virus Sequence
Virus name
HIV
Reference genome
K03455.1
Host Sequence
Chromosome
chr2
Cytoband
p16.3
Reference genome
GRCh37/hg19
Start
48556042/48328903 (Hg38)
End
48556042/48328903 (Hg38)
Orient
+
Location type
Intronic
Fragile sites / regions
FRA2S
Target gene
FOXN2
miRNAs that regulate target gene
hsa-mir-186-5p
;
hsa-mir-218-5p
;
hsa-mir-32-5p
;
hsa-mir-188-5p
;
hsa-mir-183-5p
;
hsa-mir-100-5p
;
hsa-mir-25-3p
;
hsa-mir-29a-5p
;
hsa-mir-92a-3p
;
hsa-mir-363-3p
;
hsa-mir-367-3p
;
hsa-mir-92b-3p
;
hsa-mir-548j-3p
;
hsa-mir-1277-5p
;
hsa-mir-548x-3p
;
hsa-mir-3613-3p
;
hsa-mir-548ae-3p
;
hsa-mir-548ah-3p
;
hsa-mir-548aj-3p
;
hsa-mir-548am-3p
;
hsa-mir-548aq-3p
;
hsa-mir-5582-3p
;
hsa-mir-559
;
hsa-mir-548b-5p
;
hsa-mir-548a-5p
;
hsa-mir-548c-5p
;
hsa-mir-548d-5p
;
hsa-mir-2113
;
hsa-mir-548j-5p
;
hsa-mir-548k
;
hsa-mir-548l
;
hsa-mir-548h-5p
;
hsa-mir-548i
;
hsa-mir-548w
;
hsa-mir-548y
;
hsa-mir-548o-5p
;
hsa-mir-548ab
;
hsa-mir-548ad-5p
;
hsa-mir-548ae-5p
;
hsa-mir-548ak
;
hsa-mir-548am-5p
;
hsa-mir-4724-5p
;
hsa-mir-548ap-5p
;
hsa-mir-548aq-5p
;
hsa-mir-548ar-5p
;
hsa-mir-548as-5p
;
hsa-mir-548au-5p
;
hsa-mir-548av-5p
;
hsa-mir-548ay-5p
;
hsa-mir-8054
;
hsa-mir-548bb-5p
;
hsa-mir-4495
;
hsa-mir-4662a-3p
;
hsa-mir-7109-3p
;
hsa-mir-3148
;
hsa-mir-6124
;
hsa-mir-5692a
;
hsa-mir-548n
;
hsa-mir-4427
;
hsa-mir-4680-3p
;
hsa-mir-5187-3p
;
hsa-mir-30a-5p
;
hsa-mir-30c-5p
;
hsa-mir-30d-5p
;
hsa-mir-30b-5p
;
hsa-mir-30e-5p
;
hsa-mir-6083
;
hsa-mir-651-5p
;
hsa-mir-3978
;
hsa-mir-27b-3p
;
hsa-mir-27a-3p
;
hsa-mir-5579-3p
;
hsa-mir-4791
;
hsa-mir-3201
;
hsa-mir-190b
;
hsa-mir-190a-5p
;
hsa-mir-4328
;
hsa-mir-570-3p
;
hsa-mir-3681-3p
;
hsa-mir-216a-3p
;
hsa-mir-128-3p
;
hsa-mir-4781-3p
;
hsa-mir-3074-3p
;
hsa-mir-590-5p
;
hsa-mir-21-5p
;
hsa-mir-6809-3p
;
hsa-mir-6833-3p
;
hsa-mir-4768-5p
;
hsa-mir-3191-5p
;
hsa-mir-4653-5p
;
hsa-mir-3921
;
hsa-mir-301b-5p
;
hsa-mir-301a-5p
;
hsa-mir-146a-3p
;
hsa-mir-5688
;
hsa-mir-380-3p
;
hsa-mir-411-3p
;
hsa-mir-379-3p
;
hsa-mir-497-3p
;
hsa-mir-3133
;
hsa-mir-496
Nearest miRNA
hsa-mir-1301/Upstream/951133; hsa-mir-10b/Downstream/730700;
Nearest TSS
ENST00000437798/Upstream/14193;
ENST00000616844/Downstream/17314;
Nearest CpG islands
None/Target,
chr2-CpG: 135/Upstream/13455
,
chr2-CpG: 60/Downstream/111517
Upstream sequence
ATAGCAATCCTTAAGTTTAAGTAGATGGGTTTTCTAAGTCAGATTTACTCTAAGAGCTGTAGTGGTTCTTTTCTATTGTATTTAGTAACATGTAGGGTAT
Downstream sequence
GTAAGTGTTATGTTTGAGATAATAGAACTTTATAAATTATTTAGTCACCAGTTTTTTTTTAACCTTTGTTCAAAATAGCCATTTTTCTTAAAACAGTTTT
Reference
Sunshine, S., et al. HIV Integration Site Analysis of Cellular Models of HIV Latency with a Probe-Enriched Next-Generation Sequencing Assay. J Virol,2016, 90(9): 4511-4519.
Sample Information
×
Sample name
TCM Model
Sample type
Cell line
Gender
Female
CpG Island Information
×
Download
Curate